Blood Substitutes 1996
DOI: 10.1007/978-1-4612-4114-0_1
|View full text |Cite
|
Sign up to set email alerts
|

Blood Substitutes: 1995 in the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
17
0

Year Published

1999
1999
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(18 citation statements)
references
References 67 publications
1
17
0
Order By: Relevance
“…Various types of haemoglobin-based oxygen carriers have been developed as transfusion alternatives, including intramolecular cross-linked, polymerised and polymer-conjugated haemoglobins 16. However, the cell-free structures of these chemically modified haemoglobin-based oxygen carriers resulted in retention of some of the side effects of molecular haemoglobins, such as renal toxicity, vasoconstriction, hypertension, higher incidence of infarction and death, and therefore clinical phase trials with these carriers failed.…”
Section: Discussionmentioning
confidence: 99%
“…Various types of haemoglobin-based oxygen carriers have been developed as transfusion alternatives, including intramolecular cross-linked, polymerised and polymer-conjugated haemoglobins 16. However, the cell-free structures of these chemically modified haemoglobin-based oxygen carriers resulted in retention of some of the side effects of molecular haemoglobins, such as renal toxicity, vasoconstriction, hypertension, higher incidence of infarction and death, and therefore clinical phase trials with these carriers failed.…”
Section: Discussionmentioning
confidence: 99%
“…Increased demand for blood transfusions in emergency and surgical settings has led to augmented need for red blood cell (RBC) substitutes. Different types of oxygen-carrying blood substitutes are thus being investigated [1][2][3]. One of these products is the nanobiotechnology-based polyhemoglobin (PolyHb).…”
Section: Introductionmentioning
confidence: 99%
“…Some of these fluids, which contain ultra‐pure human or bovine Hb, are currently under clinical trials. They have the potential to use these fluids in the treatment of anemia, stroke, myocardial infection, and cancer therapy 5‐7 . Hb purification or detection can be achieved by using complex centrifugation, filtration, and chemical (such as toluene and pH treatment), physical (homogenization, sonication, etc.…”
Section: Introductionmentioning
confidence: 99%
“…), chromatographic methods, or emissions sensor based systems 8,9 . However, even if the end product contains only a small amount of phospholipids, stroma residues, or other proteins, it may cause undesirable reactions such as anaphylactic reactions, immune reactions, renal malfunction, and vascular coagulation 2,7 . It can also lead to fatal consequences such as leakage of Hb from red blood cells and its uncontrolled flow to the vascular system, systemic vascular constrictions, decreases in blood volume and flow rate, increased release of immune system protectors, and loss of platelet inactivation that can cause clots in the body 10,11 .…”
Section: Introductionmentioning
confidence: 99%